| Autor: |
Lacy, Mark D., Maguire, Jason D., Barcus, Mazie J., Ling, Judith, Bangs, Michael J., Gramzinski, Robert, Basri, Hasan, Sismadi, Priyanto, Miller, Gerri B., Chulay, Jeffrey D., Fryauff, David J., Hoffman, Stephen L., Baird, J. Kevin |
| Předmět: |
|
| Zdroj: |
Clinical Infectious Diseases; 11/1/2002, Vol. 35 Issue 9, pe92, 4p |
| Abstrakt: |
Thirty-eight of 295 subjects participating in a randomized, double-blind, placebo-controlled trial of the efficacy of daily administration of atovaquone/proguanil for malaria prevention developed malaria at some time during the 20-week prophylaxis period. These subjects (3 atovaquone/proguanil recipients and 35 placebo recipients) were treated with 4 tablets of atovaquone/proguanil per day for 3 days. Atovaquone/proguanil provided safe, well-tolerated, and effective therapy for uncomplicated malaria in nonimmune Indonesians. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
